HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women.

AbstractAIM:
Determine the efficacy of 2-year continuous subantimicrobial dose doxycycline (SDD; 20 mg bid) on alveolar bone in post-menopausal osteopenic, oestrogen-deficient women undergoing periodontal maintenance in a 2-year double-blind, placebo-controlled, randomized clinical trial.
MATERIAL AND METHODS:
One-hundred and twenty-eight subjects randomized to SDD or placebo (n=64 each). Posterior vertical bite wings taken at baseline, 1 and 2 years for alveolar bone density (ABD), using radiographic absorptiometry (RA) and computer-assisted densitometric image analysis (CADIA), and alveolar bone height (ABH). Statistical analyses utilized generalized estimating equations; primary analyses were intent to treat (ITT). Results are presented as SDD versus placebo.
RESULTS:
Under ITT, there was no statistically significant effect of SDD on ABD loss (RA: p=0.8; CADIA: p=0.2) or ABH loss (p=0.2). Most sites (81-95%) were inactive. For subgroup analyses, mean CADIA was higher with SDD for non-smokers (p=0.05) and baseline probing depths > or =5 mm (p=0.003). SDD was associated with 29% lower odds of more progressive ABH loss in women >5 years post-menopausal (p=0.05) and 36% lower among protocol-adherent subjects (p=0.03).
CONCLUSIONS:
In post-menopausal osteopenic women with periodontitis, SDD did not differ overall from placebo. Based on exploratory subgroup analyses, additional research is needed to determine the usefulness of SDD in non-smokers, subjects >5 years post-menopausal and in deeper pockets. Protocol registered at (ClinicalTrials.gov). Identifier: NCT00066027.
AuthorsJeffrey B Payne, Julie A Stoner, Pirkka V Nummikoski, Richard A Reinhardt, Arthur D Goren, Mark S Wolff, Hsi-Ming Lee, James C Lynch, Robert Valente, Lorne M Golub
JournalJournal of clinical periodontology (J Clin Periodontol) Vol. 34 Issue 9 Pg. 776-87 (Sep 2007) ISSN: 0303-6979 [Print] United States
PMID17716313 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-Bacterial Agents
  • Placebos
  • Doxycycline
Topics
  • Absorptiometry, Photon
  • Aged
  • Alveolar Bone Loss (prevention & control)
  • Alveolar Process (drug effects)
  • Anti-Bacterial Agents (administration & dosage)
  • Bone Density
  • Bone Diseases, Metabolic (complications)
  • Double-Blind Method
  • Doxycycline (administration & dosage)
  • Female
  • Follow-Up Studies
  • Humans
  • Image Processing, Computer-Assisted
  • Middle Aged
  • Osteoporosis, Postmenopausal (complications)
  • Periodontal Pocket (prevention & control)
  • Periodontitis (prevention & control)
  • Placebos
  • Postmenopause
  • Radiography, Bitewing
  • Smoking
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: